Apr 15, 2026
The global healthcare industry is transforming precision medicine and targeted therapies redefine the way complex diseases, especially cancer, are treated. One of the most promising innovations emerging from nuclear medicine is Radioligand Therapies (RLTs), a treatment modality that combines molecular targeting wit...
Read More...
The Next Wave of Radioligand Therapies: 5 Candidates to Watch
Mar 20, 2026
Emerging TIL Therapies Poised to Broaden the Landscape Beyond AMTAGVI
Mar 06, 2026
BYSANTI Approval Positions Vanda to Compete in the Antipsychotic Market
Mar 02, 2026
Newsletter/Whitepaper